CRISTINA DUREZA: Open Payments
NPI 1205431525 · THE VILLAGES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,549 in 73 payments from 12 companies in 2025. Trend: 2023 $1,106 · 2024 $1,514 · 2025 $1,549
Food & beverage: $1,549
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 12 | $229 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $216 |
| Teva Pharmaceuticals USA, Inc. | 11 | $207 |
| ABBVIE INC. | 8 | $187 |
| Axsome Therapeutics, Inc. | 6 | $164 |
| Alkermes, Inc. | 8 | $155 |
| Otsuka America Pharmaceutical, Inc. | 7 | $138 |
| Lundbeck LLC | 5 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
Products named: REXULTI, INGREZZA, CAPLYTA, AUSTEDO XR, VRAYLAR, Auvelity, LYBALVI, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
